IP Library › Assignment 031296/0347
Patent Assignment
Reel/Frame 031296/0347

Assignment of Assignor's Interest

Recorded: 2013-09-27 Pages: 4
Assignor
ASTRAZENECA AB
Executed: 2012-12-10
Assignee
NAVIDEA BIOPHARMACEUTICALS, INC.
425 METRO PLACE NORTH, SUITE 300, DUBLIN, OHIO, 43017
Covered Properties (3)
Novel Heteroaryl Substituted Benzoxazoles
Patent: 7,670,591 →
Application: 11/763,151 →
Publication: US 2008/0027051
Novel Heteroaryl Substituted Benzothiazoles
Patent: 8,163,928 →
Application: 12/162,255 →
Publication: US 2009/0028787
Novel Heteroaryl Substituted Benzothiazoles
Patent: 8,957,215 →
Application: 13/453,579 →
Publication: US 2012/0207679
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 12, 2007
From: MALMSTROM, JONAS; PYRING, DAVID; SLIVO, CAN; SOHN, DANIEL
To: ASTRAZENECA AB
Reel/Frame 019819/0898 →
Assignment of Assignor's Interest Jul 28, 2008
From: GRAVENFORS, YLVA; JONASSON, CATRIN; MALMSTROM, JONAS; PYRING, DAVID
To: ASTRAZENECA AB
Reel/Frame 021303/0422 →
Security Interest May 15, 2015
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 035653/0441 →
Release of Security Interest Mar 9, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 041518/0749 →